NEW YORK, April 9 – Spotfire said Monday that it has signed agreements with both Celera and Biogen for use of Spotfire’s DecisionSite analytical software.

Celera and Spotfire will integrate DecisionSite, which enables visual analysis of product, process, and customer information from a variety of sources, with the Celera Discovery System, which provides access to Celera’s human, mouse, and fly genomes as well as other biological databases.